Anfalis-Holding SRL
Anfalis-Holding reported total assets of 56,888 € at the end of the 2024 financial year (annual accounts filed with the NBB on 31 Dec 2025).
The score of Anfalis-Holding shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Anfalis-Holding's annual accounts
| 2024 | |
|---|---|
| Net result | −758 € |
| Equity | 17,797 € |
| EBITDA | 0 € |
| Total assets | 56,888 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 31 Dec 2025
Anfalis-Holding's financial analysis
- Solvency31.3%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Anfalis-Holding
Anfalis-Holding's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1012.017.430
- VAT number
- BE1012017430
- Peppol
- Registered · 0208:1012017430 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Jul 2024
- Registered office
- 1081 Koekelberg
- Latest accounts
- 2024 · filed on 31 Dec 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Anfalis-Holding (SRL) has been based in Koekelberg since 2024, active in: retail sale of pharmaceutical products. For 2024, it reports a net loss of 758 € and equity of 17,797 €; its revenue is not published. Its solvency stands at 31.3%, below the median of its sector (37.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Anfalis-Holding
Companies in the same business, of comparable size and area, outside its group.
- TAM Pharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 63,040 €
- Pharmacie Chaussee de Gand Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 199,651 €
- MB Pharmaceutics Retail sale of pharmaceutical products Riemst · balance sheet 57,363 €
- NZpharma Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 74,203 €
- Apotheker Laura Spiritus Retail sale of pharmaceutical products Linter · balance sheet 62,639 €
- L.V. Farma Retail sale of pharmaceutical products Hasselt · balance sheet 83,799 €
- Pharmanatuur Retail sale of pharmaceutical products Affligem · balance sheet 51,561 €
- Lotte Deroover Retail sale of pharmaceutical products Boortmeerbeek · balance sheet 39,701 €
Frequently asked questions about Anfalis-Holding
What is the revenue of Anfalis-Holding?
Anfalis-Holding files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Anfalis-Holding?
In Belgium, the VAT number is the company number prefixed with BE: BE1012017430 for Anfalis-Holding, if the company is VAT-registered. Its company number (CBE) is 1012.017.430.
Where is the registered office of Anfalis-Holding?
According to the CBE register, the registered office of Anfalis-Holding is in 1081 Koekelberg.
What is the equity of Anfalis-Holding?
At the close of the 2024 financial year, the equity of Anfalis-Holding amounts to 17,797 €, a solvency of 31.3% of total assets.
Who manages Anfalis-Holding?
The register lists 1 active mandates at Anfalis-Holding. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Anfalis-Holding
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →